Investment objective & strategy
As of Dec. 29, 2025 · prospectusObjective. The Funds investment objective is appreciation of capital.
Strategy. The Fund pursues its investment objective by investing primarily in the common stock of domestic mid capitalization (mid cap) companies that offer superior growth prospects. The Fund may also invest in real estate investment trusts (REITs). The Funds investment adviser (Adviser) utilizes a mid-cap growth approach by selecting most investments from companies listed in the Russell Midcap Growth Index, an index that measures the performance of those companies with higher price-to-book ratios and higher forecasted growth values within the mid cap segment of the U.S. equity universe. The Fund considers mid cap companies to be those of a size similar to companies listed in the Russell Midcap Growth Index. As of October 31, 2025, the market capitalization of companies in … The Fund pursues its investment objective by investing primarily in the common stock of domestic mid capitalization (mid cap) companies that offer superior growth prospects. The Fund may also invest in real estate investment trusts (REITs). The Funds investment adviser (Adviser) utilizes a mid-cap growth approach by selecting most investments from companies listed in the Russell Midcap Growth Index, an index that measures the performance of those companies with higher price-to-book ratios and higher forecasted growth values within the mid cap segment of the U.S. equity universe. The Fund considers mid cap companies to be those of a size similar to companies listed in the Russell Midcap Growth Index. As of October 31, 2025, the market capitalization of companies in the Russell Midcap Growth Index ranged from $1 billion to $130 billion. As the Funds sector exposure approximates the Russell Midcap Growth Index, the Fund may, from time to time, have larger allocations to certain broad market sectors, such as information technology, healthcare, industrials and consumer discretionary. The Adviser implements its strategy using a quantitative model driven by fundamental and technical stock selection variables. This process seeks to impose strict discipline over stock selection, unimpeded by market or manager psychology. It seeks to maximize compound annual return while controlling risk relative to the Funds benchmark, the Russell Midcap Growth Index. The process also takes into account trading costs in an effort to ensure that trades are generated only to the extent they are expected to be profitable on an after-trading-cost basis. Additionally, risk is controlled through diversification constraints which limit exposure to individual companies as well as to groups of correlated companies. The Fund will invest its assets so that at least 80% of its net assets (plus any borrowings for investment purposes) are invested in mid cap investments. The Fund will notify shareholders at least 60 days in advance of any change in its investment policy. The Fund actively trades its portfolio securities in an attempt to achieve its investment objective. Active trading will cause the Fund to have an increased portfolio turnover rate and increase the Funds trading costs, which may have an adverse impact on the Funds performance. An active trading strategy will likely result in the Fund generating more short-term capital gains or losses. Short-term gains are generally taxed at a higher rate than long-term gains. Any short-term losses are used first to offset short-term gains.
Top holdings
As of April 30, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| VERTIV HOLDINGS CO | — | $373.77M | 5.87% |
| HOWMET AEROSPACE INC | — | $286.27M | 4.50% |
| AMERIPRISE FINANCIAL INC | — | $240.49M | 3.78% |
| VIKING HOLDINGS LTD | — | $192.37M | 3.02% |
| BANK OF NEW YORK MELLON CORP | — | $171.93M | 2.70% |
| VEEVA SYSTEMS-A | — | $162.50M | 2.55% |
| LULULEMON ATHLETICA INC | — | $148.40M | 2.33% |
| Federated Hermes Government Obligations Tax-Managed Fund, Institutional Class | GOFXX | $136.82M | 2.15% |
| QUANTA SVCS INC | — | $134.19M | 2.11% |
| ALNYLAM PHARMACEUTICALS INC | — | $117.23M | 1.84% |
Portfolio moves
Jan 31, 2026 → Apr 30, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Mid-Cap Growth Portfolio | 76% | 0.68% |
| Fidelity Mid Cap Growth Index Fund · FMDGX | 50% | 0.05% |
| VOYA RUSSELLTM MID CAP GROWTH INDEX PORTFOLIO · IRGJX, IRGUX, IRGVX | 49% | 0.40% |
Advisers
| Firm | Role |
|---|---|
| Federated Advisory Services Company | Adviser |
| Federated MDTA LLC | Adviser |
Footnotes
- Expense ratio as of December 29, 2025, from the fund's prospectus.
- Net assets and holdings count as of April 30, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.